Bulevirtide
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 236 publications
Bulevirtide approved by FDA for chronic hepatitis D.
Journal: The Lancet. Microbe
Published: August 12, 2026
Bulevirtide (Hepcludex) for Chronic Hepatitis Delta: A Milestone Achievement Demanding Real-World Evaluation.
Journal: The Annals of pharmacotherapy
Published: August 09, 2026
Pegylated interferon for chronic hepatitis delta: does it still have a role in the bulevirtide era?
Journal: Revista espanola de enfermedades digestivas
Published: July 13, 2026
Bulevirtide Acetate-gmod.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: June 30, 2026
FDA approval of hepcludex: a milestone in the treatment of chronic hepatitis delta virus infection.
Journal: Annals of medicine and surgery (2012)
Published: June 22, 2026
Modeling hepatitis D virus kinetics during bulevirtide monotherapy: challenges and solutions.
Journal: ArXiv
Published: June 12, 2026
Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma: Summary of the First Annual Paris International Liver Meeting 2026.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 03, 2026
Letter to the Editor: "Quantifying the Delivered Dose of Bulevirtide in Clinical Trials and Real-World Use: A Dose Recovery Study".
Journal: Journal of hepatology
Published: May 27, 2026
Mathematical modeling of HDV RNA, HBsAg, and ALT kinetics in patients with compensated cirrhosis: Insights from 96 Weeks of bulevirtide monotherapy.
Journal: Antiviral research
Published: May 20, 2026
CROI 2026: Advances in Epidemiology and Treatment of Viral Hepatitis.
Journal: Topics in antiviral medicine
Published: May 13, 2026
Last Updated: 09/26/2026